Ellie McGuire

Partner, Polaris Partners & Polaris Innovation Fund

Ellie McGuire is a partner in the Polaris Boston office and also manages the Polaris Innovation Fund.

Ellie currently serves on the boards of Muna Therapeutics, Montis Biosciences, Candesant Biomedical, Satellite Biosciences and Volastra Therapeutics, the latter of which she was the founding president. She is an expert in residence for the Harvard Office of Technology Development, serves on the key advisory board of the Blavatnik Fellowship at Harvard, and is an advisor to Nucleate.

Prior to co-founding the Polaris Innovation Fund, Ellie was the head of business development at Lyndra. She previously held leadership and consulting positions in business development, operations, and strategy in multiple life science companies including Arsia Therapeutics, Lyndra and XTuit Pharmaceuticals.